18th week of 2018 patent applcation highlights part 11 |
Patent application number | Title | Published |
20180117097 | THERAPEUTIC MICROBIOTA FOR THE TREATMENT AND/OR PREVENTION OF FOOD ALLERGY | 2018-05-03 |
20180117098 | THERAPEUTIC MICROBIOTA FOR THE TREATMENT AND/OR PREVENTION OF FOOD ALLERGY | 2018-05-03 |
20180117099 | THERAPEUTIC MICROBIOTA FOR THE TREATMENT AND/OR PREVENTION OF FOOD ALLERGY | 2018-05-03 |
20180117100 | LACTOBACILLUS SP. STRAIN HAVING ABILITY TO INHIBIT PROLIFERATION OF VIRGINAL PATHOGENIC MICROORGANISMS | 2018-05-03 |
20180117101 | GENETICALLY MODIFIED PROBIOTIC FOR THE TREATMENT OF PHENYLKETONURIA (PKU) DISEASE | 2018-05-03 |
20180117102 | COMPOSITION FOR PREVENTING OR TREATING OBESITY OR LIPID-RELATED METABOLIC DISEASE | 2018-05-03 |
20180117103 | COMPOSITION FOR ANTIOXIDATION AND IMPROVEMENT OF SKIN CONDITIONS | 2018-05-03 |
20180117104 | CANCER THERAPY WITH A PARVOVIRUS COMBINED WITH A BCL-2 INHIBITOR | 2018-05-03 |
20180117105 | Indian wax water/ zea mays | 2018-05-03 |
20180117106 | METHOD FOR CULTURING CELLS OF ACROCHAETIUM MONILIFORME RED ALGAE, METHOD FOR OBTAINING AN EXTRACT OF THE BIOMASS THEREOF, AND USE OF SAME IN COSMETICS | 2018-05-03 |
20180117107 | MIXTURE POWDERS OF PLATYCODON GRANDIFLORAS AND MOMORDICA CHARANTIA, AND METHOD FOR PRODUCING THE POWDERS | 2018-05-03 |
20180117108 | Composition Comprising Retinol, a Precursor or a Reaction Product of it and a Plant Extract from at least one Chamomilla Plant for the Treatment of Cancer | 2018-05-03 |
20180117109 | METHOD OF USING CISTANCHE TUBULOSA EXTRACT TO PREVENT, SLOW DOWN, OR TREAT AN EYE DISEASE CAUSED BY OXIDATIVE STRESS | 2018-05-03 |
20180117110 | METHOD OF TREATING CANCER | 2018-05-03 |
20180117111 | Method Of Reducing Titers Of Antibodies Specific For A Therapeutic Agent | 2018-05-03 |
20180117112 | METHODS FOR PERFORMING A CORONARY ARTERY BYPASS GRAFT PROCEDURE | 2018-05-03 |
20180117113 | Amidated Dopamine Neuron Stimulating Peptide Restoration of Mitochondrial Activity | 2018-05-03 |
20180117114 | PEPTIDES THAT MODULATE THE EFFECT OF THE CRMP: NEUROFIBROMIN COMPLEX ON SYNAPTIC TRANSMISSION | 2018-05-03 |
20180117115 | METHODS FOR ENHANCING SYNAPTOGENESIS AND NEURITOGENESIS | 2018-05-03 |
20180117116 | Conformationally Specific Viral Immunogens | 2018-05-03 |
20180117117 | Compositions containing protein loaded exosome and methods for preparing and delivering the same | 2018-05-03 |
20180117118 | COMPOSITIONS AND METHODS OF IMPROVED WOUND HEALING | 2018-05-03 |
20180117119 | AGENT FOR INDUCING AMPLIFICATION OF HEMATOPOIETIC STEM CELLS | 2018-05-03 |
20180117120 | Method to Improve Neurologic Outcomes in Temperature Managed Patients | 2018-05-03 |
20180117121 | NON-SURGICAL, LOCALIZED DELIVERY OF COMPOSITIONS FOR PLACENTAL GROWTH FACTORS | 2018-05-03 |
20180117122 | TREATMENT OF POST-BARIATRIC HYPOGLYCEMIA WITH EXENDIN (9-39) | 2018-05-03 |
20180117123 | EXENATIDE-CONTAINING COMPOSITION AND PREPARATION METHOD THEREOF | 2018-05-03 |
20180117124 | INSULIN MIMOTOPES AND METHODS OF USING THE SAME | 2018-05-03 |
20180117125 | VECTORS AND METHODS FOR REGENERATIVE THERAPY | 2018-05-03 |
20180117126 | TREATMENT OF INFLAMMATORY ILLNESSES WITH ACE2 | 2018-05-03 |
20180117127 | ENZYME COMPOSITION FOR THERAPEUTIC MANAGEMENT OF MUSCLE SORENESS | 2018-05-03 |
20180117128 | MANUFACTURE OF RECOMBINANT CLOSTRIDIUM BOTULINUM NEUROTOXINS | 2018-05-03 |
20180117129 | NEUROTOXINS AND USES THEREOF | 2018-05-03 |
20180117130 | Enzyme Formulation for Reducing Histamine Intolerance | 2018-05-03 |
20180117131 | Production and Application of Protozoa Cultures of Histomonas Meleagridis (H. Meleagridis) | 2018-05-03 |
20180117132 | FUNGAL IMMUNOGENS AND RELATED MATERIALS AND METHODS | 2018-05-03 |
20180117133 | Tolerogenic DNA Vaccine | 2018-05-03 |
20180117134 | THERAPEUTIC VACCINE FOR TREATMENT OF DIABETES TYPE 1 IN CHILDREN, APPLICATION OF THE CELL SORTER AND THE METHOD OF MULTIPLYING TREG CELLS TO PRODUCE THERAPEUTIC VACCINE FOR TREATMENT OF DIABETES TYPE 1 | 2018-05-03 |
20180117135 | CDCA1 EPITOPE PEPTIDES FOR TH1 CELLS AND VACCINES CONTAINING THE SAME | 2018-05-03 |
20180117136 | STREPTOCOCCAL VACCINE | 2018-05-03 |
20180117137 | Arenaviruses for use in the treatment and/or prevention of tumors and method for producing arenaviruses with (improved) tumor-regression properties. | 2018-05-03 |
20180117138 | MOSAIC VACCINES FOR SEROTYPE A FOOT-AND-MOUTH DISEASE VIRUS | 2018-05-03 |
20180117139 | IMMUNE COMPLEX | 2018-05-03 |
20180117140 | ENGINEERED AND MULTIMERIZED HUMAN IMMUNODEFICIENCY VIRUS ENVELOPE GLYCOPROTEINS AND USES THEREOF | 2018-05-03 |
20180117141 | DNA VACCINE COMPOSITION FOR PREVENTING AND TREATING HERPES ZOSTER, AND METHOD FOR ACTIVATING T CELLS FOR VZV ANTIGEN BY USING SAME | 2018-05-03 |
20180117142 | METHOD OF TREATING PATIENTS WITH NON-IgE MEDIATED HYPERSENSITIVITIES TO ENVIRONMENTAL ALLERGENS | 2018-05-03 |
20180117143 | PHARMACEUTICAL COMPOSITION FOR TREATMENT OF ALLERGIC REACTIONS | 2018-05-03 |
20180117144 | TARGETED CYTOSOLIC DELIVERY OF ANTIGENIC COMPOUNDS | 2018-05-03 |
20180117145 | Immunostimulatory Compositions, Particles, and Uses Related Thereto | 2018-05-03 |
20180117146 | EGFR-DIRECTED CAR THERAPY FOR GLIOBLASTOMA | 2018-05-03 |
20180117147 | COMBINATION OF ANTI-KIR AND ANTI-CTLA-4 ANTIBODIES TO TREAT CANCER | 2018-05-03 |
20180117148 | COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF TREATMENTS OF IMMUNE RELATED DISEASES AND DISORDERS | 2018-05-03 |
20180117149 | ANTAGONISTS OF IL-6 TO PREVENT OR TREAT CACHEXIA, WEAKNESS, FATIGUE, AND/OR FEVER | 2018-05-03 |
20180117150 | Combination Therapies for CD38-Positive Hematological Malignances with ANTI-CD38 Antibodies and Cyclophosphamide | 2018-05-03 |
20180117151 | PULMONARY INTRAVASCULAR NON-CLASSICAL MONOCYTES MEDIATE LUNG TRANSPLANT ISCHEMIA-REPERFUSION INJURY | 2018-05-03 |
20180117152 | ANTI-CD3 ANTIBODIES AND METHODS OF USE | 2018-05-03 |
20180117153 | METHOD OF MONOMERISATION OF RECOMBINANT ANTIBODY MOLECULES | 2018-05-03 |
20180117154 | PHASE-CHANGE NANOPARTICLE | 2018-05-03 |
20180117155 | ANTI-FUGETACTIC AGENT AND ANTI-CANCER AGENT COMBINATION THERAPY AND COMPOSITIONS FOR THE TREATMENT OF CANCER | 2018-05-03 |
20180117156 | 1-DEOXY ANALOGS OF VITAMIN D-RELATED COMPOUNDS | 2018-05-03 |
20180117157 | STABLE PHARMACEUTICAL COMPOSITION, COMPRISING AN AQUEOUS SOLUTION OF AN ANTIBODY-DERIVED THERAPEUTICALLY ACTIVE PROTEIN | 2018-05-03 |
20180117159 | Method for producing solid formulations with improved dissolution by annealing with an adjuvant | 2018-05-03 |
20180117160 | Method for the Treatment of a Solid Tumour | 2018-05-03 |
20180117161 | METHODS FOR FORMULATING ORALLY INGESTIBLE COMPOSITIONS COMPRISING LIPOPHILIC ACTIVE AGENTS | 2018-05-03 |
20180117162 | VITAMIN FUNCTIONALIZED GEL-FORMING BLOCK COPOLYMERS FOR BIOMEDICAL APPLICATIONS | 2018-05-03 |
20180117163 | VAR2CSA-DRUG CONJUGATES | 2018-05-03 |
20180117164 | Halogenated Phenols for Diagnostics, Antioxidant Protection and Drug Delivery | 2018-05-03 |
20180117165 | COVALENT CONJUGATES OF BET INHIBITORS AND ALPHA AMINO ACID ESTERS | 2018-05-03 |
20180117166 | siRNA Inhibition Of Human Antigen R Expression For Treatment of Cancer | 2018-05-03 |
20180117167 | PROCESS FOR PREPARING POLYURETHANE FOAM DRESSING COMPRISING ANTI-INFLAMMATORY AGENT | 2018-05-03 |
20180117168 | CYCLODEXTRIN-BASED POLYMERS FOR THERAPEUTIC DELIVERY | 2018-05-03 |
20180117169 | HAPTENS OF ARIPIPRAZOLE | 2018-05-03 |
20180117170 | ANTIBODY-COUPLED CYCLIC PEPTIDE TYROSINE TYROSINE COMPOUNDS AS MODULATORS OF NEUROPEPTIDE Y RECEPTORS | 2018-05-03 |
20180117171 | IMMUNOCONJUGATES FOR PROGRAMMING OR REPROGRAMMING OF CELLS | 2018-05-03 |
20180117172 | SITE-SPECIFIC ANTIBODY-DRUG CONJUGATES | 2018-05-03 |
20180117173 | METHOD OF TARGETING SENESCENT CELLS | 2018-05-03 |
20180117174 | DRUG CONJUGATES COMPRISING ANTIBODIES AGAINST CLAUDIN 18.2 | 2018-05-03 |
20180117175 | TEMPLATED NANOCONJUGATES | 2018-05-03 |
20180117176 | POROUS SILICON MICROPARTICLE-BASED CANCER VACCINES AND METHODS FOR POTENTIATING ANTI-TUMOR IMMUNITY | 2018-05-03 |
20180117177 | CRYSTALS AS HOSTS FOR ENTRAPMENT AND SLOW RELEASE OF COMPOUNDS | 2018-05-03 |
20180117178 | AAV VECTOR FOR TREATMENT OF FRIEDREICH'S ATAXIA | 2018-05-03 |
20180117179 | COMPLEXES OF RNA AND CATIONIC PEPTIDES FOR TRANSFECTION AND FOR IMMUNOSTIMULATION | 2018-05-03 |
20180117180 | DNA-based plasmid formulations and vaccines and prophylactics containing the same | 2018-05-03 |
20180117181 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF FABRY DISEASE | 2018-05-03 |
20180117182 | THROMBUS IMAGING APTAMERS AND METHODS OF USING SAME | 2018-05-03 |
20180117183 | FLUORESCENT COMPOUND COMPRISING A FLUOROPHORE CONJUGATED TO A pH-TRIGGERED POLYPEPTIDE | 2018-05-03 |
20180117184 | Quantum Dots for Diagnostic Imaging | 2018-05-03 |
20180117185 | Magnetic Nanoparticles for Disease Diagnostics | 2018-05-03 |
20180117186 | MAGNETIC PARTICLES FOR USE IN MAGNETIC RESONANCE IMAGING THERMOMETRY | 2018-05-03 |
20180117187 | TIN SULFIDE QUANTUM DOTS FOR IN VIVO NEAR INFRARED IMAGING | 2018-05-03 |
20180117188 | RADIOLABELED ACTIVE TARGETING PHARMACEUTICAL COMPOSITION AND THE USE THEREOF | 2018-05-03 |
20180117189 | SYSTEMS AND METHODS FOR COMBINED HIGH INTENSITY NARROW SPECTRUM AND NON- HIGH INTENSITY NARROW SPECTRUM LIGHTING FOR SURFACE DISINFECTION IN VARIABLY OCCUPIED ENVIRONMENTS | 2018-05-03 |
20180117190 | High Intensity Narrow Spectrum Light Indicator Systems | 2018-05-03 |
20180117191 | Systems, Devices, and/or Methods for Sterilizing Surfaces | 2018-05-03 |
20180117192 | SANITIZING DEVICE AND METHOD FOR SANITIZING ARTICLES | 2018-05-03 |
20180117193 | Multi-Array Lighting System for Providing High Intensity Narrow Spectrum Light | 2018-05-03 |
20180117194 | Ultraviolet-Based Detection and Sterilization | 2018-05-03 |
20180117195 | Diffusive Light Illuminator | 2018-05-03 |
20180117196 | PLASMA SYSTEMS DRIVEN BY DC VOLTAGE AND METHODS OF USING THE SAME | 2018-05-03 |
20180117197 | BACTERIA REMOVING WATER GENERATION DEVICE | 2018-05-03 |